10-15
2026
影响因子区间
—
平台估算
6%
2025
中国作者发文占比
—
收费
期刊简介:Acta Neuropathologica aims to publish the best papers on pathology of neurological disease, as well as experimental studies on molecular and cellular mechanisms using in vitro and in vivo models, ideally validated by analysis of human tissues.The journal publishes Original Papers, Review Articles, Case Reports, and Scientific Correspondence (Letters).Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identiy of the subjects under study should be omitted.Reports of animal experiments must state that the "Principles of laboratory animal care" (NIH publication No. 86-23, revised 1985) were followed, as well as specific national laws (e.g. the current version of the German Law on the Protection of Animals) where applicable.The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or for failure to fulfil the above-mentioned requirements.
【译文】《Acta Neuropathologica》致力于发表关于神经系统疾病病理学最佳论文,以及使用体外和体内模型进行的分子和细胞机制实验研究,理想情况下通过分析人类组织得到验证。该期刊发表原创论文、综述文章、病例报告和科学通讯(信件)。提交出版的手稿必须包含一份声明,说明所有人类研究都已由适当的伦理委员会审查,因此已按照1964年赫尔辛基宣言的适当版本中规定的伦理标准进行。在文本中还应明确说明,所有参与者在被纳入研究之前都提供了知情同意。可能泄露研究受试者身份的详细信息应予以省略。动物实验报告必须声明遵循了“实验室动物护理原则”(NIH出版物No. 86-23,1985年修订),以及适用的具体国家法律(例如,德国动物保护法的当前版本)。编辑保留拒绝不符合上述要求的稿件的权利。作者将被追究虚假陈述或未能履行上述要求的责任。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 影响因子区间 | 10-15 | 暂无 |